KZR
insider transactionsKezar Life Sciences, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 90d
No open-market buys or sells in this period — showing all activity (grants, exercises & gifts).
-
Other·D
Chief Operating Officer
$0
114.7K sh · 9 lots
Own -100%
-
Other·U
Chief Operating Officer
—
2.7K sh
-
Other·D
Director
$0
23.9K sh · 6 lots
Own -100%
-
Other·D
Director
$0
21.3K sh · 5 lots
Own -100%
-
Other·D
CEO
$0
329.0K sh · 11 lots
Own -100%
-
Other·U
CEO
—
43.1K sh
-
Other·D
Director
$0
20.9K sh · 8 lots
Own -100%
-
Other·U
Director
—
6.4K sh
-
Other·D
Director
$0
21.4K sh · 7 lots
Own -100%
-
Other·D
Director
$0
329.3K sh · 11 lots
Own -100%
-
Other·U
Director
—
43.6K sh · 3 lots
-
Other·D
SVP, Corporate Controller
$0
75.0K sh · 13 lots
Own -100%
-
Other·U
SVP, Corporate Controller
—
2.7K sh
-
Other·D
Director
$0
27.7K sh · 10 lots
Own -100%
-
Other·D
Belsky Marc KEY
Chief Financial Officer
$0
160.3K sh · 10 lots
Own -100%
-
Other·U
Belsky Marc KEY
Chief Financial Officer
—
1.7K sh · 2 lots
-
Other·D
Director
$0
18.7K sh · 5 lots
Own -100%
-
Other·U
Director
—
89.1K sh
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 11, 2026 | Schiller Mark C. | Other D | 114.7K9 lots | $0 |
| May 11, 2026 | Schiller Mark C. | Other U | 2.7K | — |
| May 11, 2026 | Klearman Micki | Other D | 23.9K6 lots | $0 |
| May 11, 2026 | Wallace Courtney | Other D | 21.3K5 lots | $0 |
| May 11, 2026 | Kirk Christopher J. KEY | Other D | 329.0K11 lots | $0 |
| May 11, 2026 | Kirk Christopher J. KEY | Other U | 43.1K | — |
| May 11, 2026 | Kauffman Michael | Other D | 20.9K8 lots | $0 |
| May 11, 2026 | Kauffman Michael | Other U | 6.4K | — |
| May 11, 2026 | Garner Elizabeth | Other D | 21.4K7 lots | $0 |
| May 11, 2026 | Fowler John Franklin | Other D | 329.3K11 lots | $0 |
| May 11, 2026 | Fowler John Franklin | Other U | 43.6K3 lots | — |
| May 11, 2026 | Chiang Pichi Luo | Other D | 75.0K13 lots | $0 |
| May 11, 2026 | Chiang Pichi Luo | Other U | 2.7K | — |
| May 11, 2026 | COOPER GRAHAM K | Other D | 27.7K10 lots | $0 |
| May 11, 2026 | Belsky Marc KEY | Other D | 160.3K10 lots | $0 |
| May 11, 2026 | Belsky Marc KEY | Other U | 1.7K2 lots | — |
| May 11, 2026 | BERGER FRANKLIN M | Other D | 18.7K5 lots | $0 |
| May 11, 2026 | BERGER FRANKLIN M | Other U | 89.1K | — |
Buy Sell Non-market (grant · exercise · gift)
About KZR insider trading
This page tracks insider transactions for Kezar Life Sciences, Inc. (KZR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.